[
  {
    "ts": null,
    "headline": "What Moved Markets This Week",
    "summary": "Wall Street faced its worst week since May amid weak jobs data, trade tensions, and a hawkish Federal Reserve.",
    "url": "https://finnhub.io/api/news?id=4e77039fa9e29acaa79062b5c5c0531b736c0f09633de5a0b88301bdff0e02ac",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754120534,
      "headline": "What Moved Markets This Week",
      "id": 136181377,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/962938042/image_962938042.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Wall Street faced its worst week since May amid weak jobs data, trade tensions, and a hawkish Federal Reserve.",
      "url": "https://finnhub.io/api/news?id=4e77039fa9e29acaa79062b5c5c0531b736c0f09633de5a0b88301bdff0e02ac"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Inc (MRNA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Cost ...",
    "summary": "Despite a net loss, Moderna Inc (MRNA) showcases resilience with significant cost cuts, new FDA approvals, and a robust cash position.",
    "url": "https://finnhub.io/api/news?id=62f327842c048e7624e757d5a05c2d38279c5a9114b6120cd8a15b8a239c10c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754118308,
      "headline": "Moderna Inc (MRNA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Cost ...",
      "id": 136183900,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Despite a net loss, Moderna Inc (MRNA) showcases resilience with significant cost cuts, new FDA approvals, and a robust cash position.",
      "url": "https://finnhub.io/api/news?id=62f327842c048e7624e757d5a05c2d38279c5a9114b6120cd8a15b8a239c10c0"
    }
  }
]